Printer Friendly
The Free Library
14,558,602 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Revised U.S. Adult and Adolescent Antiretroviral Treatment Guidelines; also Revised Pediatric Guidelines.


Small but important revisions to the U.S. Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents were published in a revised document on November 10, 2003. The latest HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  treatment guidelines are always available at: http://www.aidsinfo.nih.gov/guidelines/

The revised guidelines include warnings against two three-drug NRT NRT Nicotine Replacement Therapy
NRT Norm-Referenced Test
NRT near real time
NRT Non-Real-Time
NRT National Response Team
NRT Tokyo, Japan - Narita (Airport Code)
NRT Net Registered Tonnage
! combinations that should never be used as a triple regimen (abacavir + tenofovir + lamivudine, and tenofovir + didanosine didanosine /di·dan·o·sine/ (-dan´o-sen) 2, an analogue of dideoxyadenosine; an antiretroviral agent used for the treatment of advanced HIV-1 infection and acquired immunodeficiency syndrome, administered orally.  + lamivudine), because these regimens failed to control viral load in treatment-naive volunteers in recent clinical trials, leading to development of viral resistance in some patients. The problem with these regimens is well known--but unless the warning is in the guidelines, some physicians with little HIV experience may make a mistake.

The warning against combining d4T + ddl (stavudine plus didanosine) due to risk of toxicities now clearly applies not only in pregnancy but to anyone (unless the benefits outweigh the risks for a particular patient). The previous edition of the guidelines had been criticized for being ambiguous on this.

The revised guidelines warn against combining atazanavir + indinavir indinavir /in·di·na·vir/ (in-di´nah-vir) an HIV protease inhibitor that causes formation of immature, noninfectious viral particles; used as the sulfate salt in the treatment of HIV infection and AIDS.  (possible worse hyperbilirubinemia), and FTC FTC

See Federal Trade Commission (FTC).
 + 3TC (similar resistance profile, without additional benefit).

And they also include additional information on T-20 (enfuvirtide).

Atazanavir and FTC have been added to the guidelines as potential alternative drugs in certain regimens. (The new guidelines also make it clear that "alternative" recommendations can be the preferred treatment for some patients.)

This edition includes a helpful "What's New in This Document?" section just after the cover page.

Patients who want to check to see how their treatment compares should note that much of the information is in the tables at the end of the document. Remember that HIV-expert physicians may have good reason for not following the guidelines in some cases.

Pediatric pediatric /pe·di·at·ric/ (pe?de-at´rik) pertaining to the health of children.

pe·di·at·ric
adj.
Of or relating to pediatrics.
 HIV Guidelines Revised

A revised Guidelines for the Use of Antiretroviral Agents in Pediatric HIV Infection was published November 26, 2003, by the U.S. Department of Health and Human Services Noun 1. Department of Health and Human Services - the United States federal department that administers all federal programs dealing with health and welfare; created in 1979
Health and Human Services, HHS
. It is also available at the U.S. government Web site for official HIV treatment and related guidelines: http://www.aidsinfo.nih.gov/guidelines/
COPYRIGHT 2003 John S. James
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2003, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Author:James, John S.
Publication:AIDS Treatment News
Geographic Code:1USA
Date:Nov 28, 2003
Words:347
Previous Article:New neuropathy treatment guidelines.(Brief Article)
Next Article:AIDS treatment news: changes next year.
Topics:



Related Articles
Approved Drugs for HIV/AIDS or AIDS-related Conditions.(Pamphlet)
Nevirapine Warning on Post-Exposure Prophylaxis.
Retroviruses Conference: Johns Hopkins Report.(Hopkins HIV Report)
Protease inhibitors in children: combination therapy reduced death by two thirds.
New guidelines on metabolic complications of HIV and antiretroviral treatment.(Brief Article)
Checking your drug interactions.
New treatment guidelines published October 29.(Brief Article)
Adult HIV treatment guidelines updated.
Research on postexposure prophylaxis for HIV.
U.S. guidelines: adult/adolescent revision published October 10, 2006; perinatal guidelines October 12; pediatric guidelines October 26.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles